scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1049138688 |
P356 | DOI | 10.1038/ONC.2011.157 |
P698 | PubMed publication ID | 21602886 |
P50 | author | Thomas Braun | Q40760364 |
P2093 | author name string | A Schneider | |
W Schulz-Schaeffer | |||
H Hahn | |||
A Frommhold | |||
A Zibat | |||
F Nitzki | |||
P2860 | cites work | Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma | Q57243407 |
Intrinsic phenotypic diversity of embryonic and fetal myoblasts is revealed by genome-wide gene expression analysis on purified cells. | Q59120502 | ||
Genetic mapping of a Ptch1-associated rhabdomyosarcoma susceptibility locus on mouse chromosome 2 | Q63951631 | ||
Fishing for the origins of cancer | Q80421832 | ||
Different autonomous myogenic cell populations revealed by ablation of Myf5-expressing cells during mouse embryogenesis | Q80958958 | ||
A mammalian patched homolog is expressed in target tissues of sonic hedgehog and maps to a region associated with developmental abnormalities | Q24315810 | ||
Sonic hedgehog in temporal control of somite formation | Q24633176 | ||
Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase | Q29615040 | ||
Conservation of the hedgehog/patched signaling pathway from flies to mice: induction of a mouse patched gene by Hedgehog | Q29615369 | ||
Hedgehog: functions and mechanisms | Q29619190 | ||
Rhabdomyosarcoma--working out the pathways | Q33739291 | ||
Bortezomib reverses a post-translational mechanism of tumorigenesis for patched1 haploinsufficiency in medulloblastoma. | Q33772264 | ||
Myf5 is a direct target of long-range Shh signaling and Gli regulation for muscle specification | Q34108593 | ||
The hedgehog signaling pathway in cancer | Q34576345 | ||
Cellular heterogeneity during vertebrate skeletal muscle development | Q36870830 | ||
Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells | Q36882529 | ||
Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin. | Q37598845 | ||
Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. | Q37598848 | ||
Effects of RAS on the genesis of embryonal rhabdomyosarcoma. | Q38301662 | ||
Time-point and dosage of gene inactivation determine the tumor spectrum in conditional Ptch knockouts | Q38510595 | ||
Nevoid basal-cell carcinoma syndrome | Q39759038 | ||
Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome | Q42455110 | ||
Detecting tissue-specific alternative splicing and disease-associated aberrant splicing of the PTCH gene with exon junction microarrays | Q42484854 | ||
Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development | Q42486654 | ||
Unbalanced overexpression of the mutant allele in murine Patched mutants | Q42521492 | ||
Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death | Q43409060 | ||
Antitumor effects of a combined 5-aza-2'deoxycytidine and valproic acid treatment on rhabdomyosarcoma and medulloblastoma in Ptch mutant mice | Q46156118 | ||
Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues | Q48189802 | ||
Profiling the molecular difference between Patched- and p53-dependent rhabdomyosarcoma | Q48714160 | ||
The Hedgehog receptor Patched controls lymphoid lineage commitment. | Q50899169 | ||
Gli2 and Gli3 have redundant and context-dependent function in skeletal muscle formation. | Q52062326 | ||
Apoptosis of epaxial myotome in Danforth's short-tail (Sd) mice in somites that form following notochord degeneration. | Q52182447 | ||
Proliferative lesions of oviduct and uterus in CD-1 mice exposed prenatally to tamoxifen. | Q53439470 | ||
P433 | issue | 43 | |
P921 | main subject | embryonal rhabdomyosarcoma | Q5370233 |
heterozygosity | Q124059385 | ||
P304 | page(s) | 4428-4436 | |
P577 | publication date | 2011-05-23 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | Uncommitted precursor cells might contribute to increased incidence of embryonal rhabdomyosarcoma in heterozygous Patched1-mutant mice | |
P478 | volume | 30 |
Q26852801 | A comparative review of canine and human rhabdomyosarcoma with emphasis on classification and pathogenesis |
Q41847776 | Calcitriol inhibits hedgehog signaling and induces vitamin d receptor signaling and differentiation in the patched mouse model of embryonal rhabdomyosarcoma |
Q60046466 | Canonical WNT/β-Catenin Signaling Plays a Subordinate Role in Rhabdomyosarcomas |
Q43080027 | Hedgehog-driven myogenic tumors recapitulate skeletal muscle cellular heterogeneity |
Q38834036 | Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells |
Q33688560 | MiR-214 and N-ras regulatory loop suppresses rhabdomyosarcoma cell growth and xenograft tumorigenesis |
Q26783611 | Non-Canonical Hh Signaling in Cancer-Current Understanding and Future Directions |
Q35832313 | Overexpression of mutant Ptch in rhabdomyosarcomas is associated with promoter hypomethylation and increased Gli1 and H3K4me3 occupancy |
Q36253616 | Patched knockout mouse models of Basal cell carcinoma |
Q38105879 | Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcoma. |
Q37232227 | Targeting hedgehog signaling in cancer: research and clinical developments |
Q33586736 | Targeting hedgehog signaling reduces self-renewal in embryonal rhabdomyosarcoma |
Q36240079 | The Hedgehog pathway: role in cell differentiation, polarity and proliferation |
Q37649642 | Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice. |
Q90266281 | Wnt, Notch, and TGF-β Pathways Impinge on Hedgehog Signaling Complexity: An Open Window on Cancer |
Search more.